Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 1
1(50.0%)
Phase 2
1(50.0%)
2Total
Phase 1(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05483751Recruiting

Micro- and Macrovascular Parameters in Delayed Cerebral Ischemia

Role: collaborator

NCT03935724Phase 2Unknown

Stem Cells in Spinal Cord Injury

Role: lead

NCT04205019Phase 1Completed

Safety Stem Cells in Spinal Cord Injury

Role: lead

NCT02118740Unknown

Bone Marrow Collection in Healthy Volunteers (iCell)

Role: collaborator

All 4 trials loaded